Invus Advisors, L.L.C., Director, 10% Owner at LEXICON PHARMACEUTICALS, INC. (LXRX), bought 311,454 shares at $10.21 ($3.2M) on 2017-11-15, disclosed to the SEC on 2017-11-17.
Open-market purchase of $3.2M LXRX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.21 | 130,727 | $1.3M | 42.2% |
| 2 | $10.21 | 130,727 | $1.3M | 42.2% |
| 3 | $9.85 | 50,000 | $493K | 15.6% |
| Total | $10.15 avg | 311,454 | $3.2M | 100% |
| Filing → |
| LXRX | BUY | 2009-10-15 | $23.2M | — | Filing → |
| LXRX | BUY | 2008-05-02 | $1.3M | — | Filing → |
| LXRX | BUY | 2007-08-24 | — | — | Filing → |